Literature DB >> 8820343

Distortion product otoacoustic emission test of sensorineural hearing loss: performance regarding sensitivity, specificity and receiver operating characteristics.

D O Kim1, J Paparello, M D Jung, J Smurzynski, X Sun.   

Abstract

The performance of distortion product otoacoustic emissions (DPOEs) as a frequency-specific test of sensorineural hearing loss was evaluated in 142 ears of human adults with normal middle-ear function. The DPOE was measured with the stimulus levels of the two tones equal to 65 dB SPL (re 20 mu Pa) and the ratio between the two frequencies 1.2. In the DPOE test, the cochlear function of an ear at a test frequency was predicted to be normal or abnormal depending upon whether the DPOE level with the geometric mean of the two stimulus frequencies at the test frequency was greater or less than a criterion. The DPOE test outcomes were evaluated against the pure-tone hearing threshold as the standard. We found the sensitivity, specificity and predictive efficiency of the test to be 85-89% at 6000 and 4000 Hz, 82-83% at 2000 Hz and 78-79% at 1000 Hz, respectively. The performance was also evaluated using decision theory in terms of the area under the receiver operating characteristics. The latter was found to range from 0.90 (for 1000 Hz) to 0.94 (for 6000 Hz). These findings support the conclusion that the DPOEs can form a useful frequency-specific objective test of cochlear function.

Entities:  

Mesh:

Year:  1996        PMID: 8820343     DOI: 10.3109/00016489609137705

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  18 in total

1.  Influence of calibration method on distortion-product otoacoustic emission measurements: I. test performance.

Authors:  Sienna R Burke; Abigail R Rogers; Stephen T Neely; Judy G Kopun; Hongyang Tan; Michael P Gorga
Journal:  Ear Hear       Date:  2010-08       Impact factor: 3.570

2.  A validation and potential clinical application of multivariate analyses of distortion-product otoacoustic emission data.

Authors:  Michael P Gorga; Darcia M Dierking; Tiffany A Johnson; Kathryn L Beauchaine; Cassie A Garner; Stephen T Neely
Journal:  Ear Hear       Date:  2005-12       Impact factor: 3.570

3.  Distortion product otoacoustic emissions: cochlear-source contributions and clinical test performance.

Authors:  Tiffany A Johnson; Stephen T Neely; Judy G Kopun; Darcia M Dierking; Hongyang Tan; Connie Converse; Elizabeth Kennedy; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2007-12       Impact factor: 1.840

4.  Distribution of standing-wave errors in real-ear sound-level measurements.

Authors:  Susan A Richmond; Judy G Kopun; Stephen T Neely; Hongyang Tan; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2011-05       Impact factor: 1.840

5.  Prophylactic etanercept treatment in cisplatin ototoxicity.

Authors:  Sinem Dasli; Murat Topdag; Ahmet Mutlu; Ahmet Kara; Murat Ozturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-20       Impact factor: 2.503

6.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

7.  Multivariate DPOAE metrics for identifying changes in hearing: perspectives from ototoxicity monitoring.

Authors:  Dawn Konrad-Martin; Kelly M Reavis; Garnett P McMillan; Marilyn F Dille
Journal:  Int J Audiol       Date:  2012-02       Impact factor: 2.117

8.  Do "optimal" conditions improve distortion product otoacoustic emission test performance?

Authors:  Benjamin J Kirby; Judy G Kopun; Hongyang Tan; Stephen T Neely; Michael P Gorga
Journal:  Ear Hear       Date:  2011 Mar-Apr       Impact factor: 3.570

9.  Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.

Authors:  Tiffany A Johnson; Stephen T Neely; Judy G Kopun; Darcia M Dierking; Hongyang Tan; Michael P Gorga
Journal:  Ear Hear       Date:  2010-02       Impact factor: 3.570

10.  Using benefit-cost ratio to select Universal Newborn Hearing Screening test criteria.

Authors:  Heather L Porter; Stephen T Neely; Michael P Gorga
Journal:  Ear Hear       Date:  2009-08       Impact factor: 3.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.